# Berberine: Is It Really "Nature's Ozempic"?

No, berberine is not "nature's Ozempic." It shares no mechanism with GLP-1 drugs like semaglutide. Instead it activates AMPK, the same pathway as metformin, just more weakly. That is why "plant metformin" is the honest label. Expect modest effects on blood sugar and LDL, mostly as an add-on in type 2 diabetes, not Ozempic-style weight loss.

Short answer: no. Berberine works more like metformin than like Ozempic, with small but real effects on blood sugar and cholesterol. Here is what the trials actually show, and where the hype falls apart.

## On this page

- Is berberine really "nature's Ozempic"?
- Does berberine actually lower blood sugar and cholesterol?
- How much weight can you actually lose with berberine?
- How do you take berberine, and what about dihydroberberine?
- What are the real risks and drug interactions of berberine?
- Is berberine legal in Germany, and is it worth taking?

## FAQ

- Is berberine the same as Ozempic or a GLP-1 drug?
- How much weight can you lose taking berberine?
- Is berberine as good as metformin for blood sugar?
- What is the best dose of berberine and when should you take it?
- Can you take berberine with statins or other medications?
- Who should not take berberine?
- Is berberine legal to buy in Germany and the EU?
- Is dihydroberberine better than regular berberine?

## Sources

- Xie W, Su F, Wang G, et al.. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.1015045
- Wang J, Bi C, Xi H, Wei F. (2024). Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2024.1455534
- Yin J, Xing H, Ye J. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. https://doi.org/10.1016/j.metabol.2008.01.013
- Amini MR, Sheikhhossein F, Naghshi S, et al.. (2020). Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. https://doi.org/10.1016/j.ctim.2020.102337
- Liu D, Zhao H, Zhang Y, Hu J, Xu H. (2025). Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1572197
- Ren G, Ding YW, Wang LL, Jiang JD. (2023). Berberine stimulates lysosomal AMPK independent of PEN2 and maintains cellular AMPK activity through inhibiting the dephosphorylation regulator UHRF1. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2023.1148611
- Moon JM, Ratliff KM, Hagele AM, Stecker RA, Mumford PW, Kerksick CM. (2021). Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients. https://doi.org/10.3390/nu14010124
- Guo J, Chen H, Zhang X, et al.. (2021). The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2021/2074610
- Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. (2006). Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. https://doi.org/10.2337/db06-0006
- Ju J, Li J, Lin Q, Xu H. (2018). Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials. Phytomedicine. https://doi.org/10.1016/j.phymed.2018.09.212
- Wu X, Li Q, Xin H, Yu A, Zhong M. (2005). Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-005-0952-3
- Teruo Murakami, Erik Bodor, Nicholas Bodor. (2023). Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2023.2203857
- Liang Y, Xu X, Yin M, et al.. (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocrine Journal. https://doi.org/10.1507/endocrj.EJ18-0109
- Hernandez AV, Hwang J, Nasreen I, et al.. (2024). Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis. Journal of Dietary Supplements. https://doi.org/10.1080/19390211.2023.2212762
- Xiong P, Niu L, Talaei S, et al.. (2020). The effect of berberine supplementation on obesity indices: a dose-response meta-analysis and systematic review of randomized controlled trials. Complementary Therapies in Clinical Practice. https://doi.org/10.1016/j.ctcp.2020.101113
- Chan E. (1993). Displacement of bilirubin from albumin by berberine. Biology of the Neonate. https://doi.org/10.1159/000243932
- Mathioudakis N. (2025). A Berberine Derivative for Treatment of Type 2 Diabetes. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.62195

_Full guide: https://longevity-switzerland.com/en/guide/berberin-natuerliches-ozempic_

---

_Canonical: https://longevity-switzerland.com/en/guide/berberin-natuerliches-ozempic · Part of Longevity Cities · Updated 2026-06-22_